Site-directed mutagenesis of cysteine residues of large neutral amino acid transporter LAT1

被引:26
作者
Boado, RJ [1 ]
Li, JY [1 ]
Chu, C [1 ]
Ogoshi, F [1 ]
Wise, P [1 ]
Pardridge, WM [1 ]
机构
[1] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 2005年 / 1715卷 / 02期
关键词
phenylketonuria; PKU; brain amino acid transport; LAT1; site-directed mutagenesis;
D O I
10.1016/j.bbamem.2005.07.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The large neutral amino acid transporter type 1, LAT1, is the principal neutral amino acid transporter expressed at the blood-brain barrier (BBB).Owing to the high affinity (low K-m) of the LAT1 isoform, BBB amino acid transport in vivo is very sensitive to transport competition effects induced by hyperaminoacidemias, such as phenylketonuria. The low K-m of LAT1 is a function of specific amino acid residues, and the transporter is comprised of 12 phylogenetically conserved cysteine (Cys) residues. LAT1 is highly sensitive to inhibition by inorganic mercury, but the specific cysteine residue(s) of LAT1 that account for the mercury sensitivity is not known. LAT1 forms a heterodimer with the 4F2hc heavy chain, which are joined by a disulfide bond between Cys(160) of LAT1 and Cys(110) of 4F2hc. The present studies use site-directed mutagenesis to convert each of the 12 cysteines of LAT1 and each of the 2 cysteines of 4F2hc into serine residues. Mutation of the cysteine residues of the 4F2hc heavy chain of the hetero-dimeric transporter did not affect transporter activity. The wild type LAT1 was inhibited by HgCl2 with a K-i of 0.56 +/- 0.11 mu M. The inhibitory effect of HgCl2 for all 12 LAT1 Cys mutants was examined. However, except for the C439S mutant, the inhibition by HgCl2 for 11 of the 12 Cys mutants was comparable to the wild type transporter. Mutation of only 2 of the 12 cysteine residues of the LAT I light chain, Cys(88) and CYS439, altered amino acid transport. The V-max was decreased 50% for the C88S mutant. A kinetic analysis of the C439S mutant could not be performed because transporter activity was not significantly above background. Confocal microscopy showed the C439S LAT1 mutant was not effectively transferred to the oocyte plasma membrane. These studies show that the CYS439 residue of LAT1 plays a significant role in either folding or insertion of the transporter protein in the plasma membrane. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:104 / 110
页数:7
相关论文
共 16 条
[1]   Structure and mechanism of the lactose permease of Escherichia coli [J].
Abramson, J ;
Smirnova, I ;
Kasho, V ;
Verner, G ;
Kaback, HR ;
Iwata, S .
SCIENCE, 2003, 301 (5633) :610-615
[2]   Site-directed mutagenesis of rabbit LAT1 at amino acids 219 and 234 [J].
Boado, RJ ;
Li, JY ;
Pardridge, WM .
JOURNAL OF NEUROCHEMISTRY, 2003, 84 (06) :1322-1331
[3]   Selective expression of the large neutral amino acid transporter at the blood-brain barrier [J].
Boado, RJ ;
Li, JY ;
Nagaya, M ;
Zhang, C ;
Pardridge, WM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (21) :12079-12084
[4]   INHIBITION OF AMINO-ACID TRANSPORT AND PROTEIN-SYNTHESIS BY HGCL2 AND METHYLMERCURY IN ASTROCYTES - SELECTIVITY AND REVERSIBILITY [J].
BROOKES, N ;
KRISTT, DA .
JOURNAL OF NEUROCHEMISTRY, 1989, 53 (04) :1228-1237
[5]   ENDOTHELIAL SURFACE SULFHYDRYL-GROUPS IN BLOOD-BRAIN-BARRIER TRANSPORT OF NUTRIENTS [J].
HERVONEN, H ;
STEINWALL, O .
ACTA PHYSIOLOGICA SCANDINAVICA, 1984, 121 (04) :343-351
[6]   Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli [J].
Huang, YF ;
Lemieux, MJ ;
Song, JM ;
Auer, M ;
Wang, DN .
SCIENCE, 2003, 301 (5633) :616-620
[7]   Thiol modification of cysteine 327 in the eighth transmembrane domain of the light subunit xCT of the heteromeric cystine/glutamate antiporter suggests close proximity to the substrate binding site/permeation pathway [J].
Jiménez-Vidal, M ;
Gasol, E ;
Zorzano, A ;
Nunes, V ;
Palacín, M ;
Chillarón, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (12) :11214-11221
[8]   Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98) [J].
Kanai, Y ;
Segawa, H ;
Miyamoto, K ;
Uchino, H ;
Takeda, E ;
Endou, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) :23629-23632
[9]  
Li JY, 2001, J PHARMACOL EXP THER, V299, P735
[10]   Cloned blood-brain barrier adenosine transporter is identical to the rat concentrative Na+ nucleoside cotransporter CNT2 [J].
Li, JY ;
Boado, RJ ;
Pardridge, WM .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (08) :929-936